| Issuer | % of Class | Filed |
|---|---|---|
|
ABVC Biopharma, Inc.
13D/A
Amendment 1
ABVC · 00091F304
|
18.5% |
7/15/2025
Event 7/10/2025
|
|
ABVC Biopharma, Inc.
13D
ABVC · 00091F304
|
17.4% |
6/3/2025
Event 5/13/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.